News on the people who matter.
The Flagship Pioneering founder studied at McGill and MIT, started his first company in 1987 and now chairs Moderna’s board. In October, Forbes ranked him No. 17 on its list of America’s greatest living optimists.
His firm, Camino Partners, invested in Intake Breathing on Wednesday, Oct. 28. It is the biggest deal in Camino’s history, according to Entrepreneur.
HHS said on Wednesday, Oct. 28, that it will not take enforcement action when small compounding pharmacies make six peptides the FDA has not approved.
The agency granted accelerated approval on Oct. 30 to a treatment for a rare airway disease. Inovio says it is the first FDA-approved DNA medicine.
By his account, Hosein grew a medical-device territory from $200,000 to $12 million before a turn through nightlife and a return to healthcare.
